课题基金 / 基金详情

Role of the matrix-degrading enzymes and their inhibitors on invasion and metastasis of oral SCC

Role of the matrix-degrading enzymes and their inhibitors on invasion and metastasis of oral SCC
基质降解酶及其抑制剂在口腔鳞状细胞癌侵袭和转移中的作用
批准号:
08672315
负责人:
KAWAMATA Hitoshi
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

KAWAMATA Hitoshi的其他基金

相似基金

相关文献

中文摘要
翻译
我们检测了明胶酶及其抑制物在口腔鳞状细胞癌BHY(非转移性)和HN(转移性)细胞中的表达。两个细胞都表达几种明胶酶。此外,BHY细胞分泌原MMP7和原L蛋白,而HN细胞分泌大量活性MMP2。HN细胞可分泌TIMP1,但仅有少量TIMP2。癌细胞分泌的基质金属蛋白酶2和组织蛋白酶L的净活性可能分别与口腔癌细胞的淋巴转移和骨侵袭有关。癌细胞巢中的明胶溶解活性明显高于正常牙龈上皮。转移癌癌细胞巢中活性MMP2活性显著高于未转移癌(p<0.05)。我们还用RT-PCR检测了口腔鳞癌患者外周血中循环癌细胞的存在,检测了12例口腔鳞癌患者中11例呈阳性结果。但血源性CK20基因与肿瘤转移的关系尚不明确。所有无瘤幸存者的检测结果均为阴性。肿瘤细胞中活性MMP2的表达可作为预测肿瘤转移的指标,外周血中CK20mRNA的表达可作为口腔鳞癌患者肿瘤复发的指标。然后我们分析了该基因在口腔癌转移潜能中的作用。但TSC-22正、反义基因均不影响TYS细胞的转移潜能。转移性口腔癌与非转移性口腔癌组织中TSC-22mRNA的表达差异无统计学意义。
英文摘要
We examined the expression of gelatinases and their inhibitors in human oral SCC cells, BHY (non-metastatic) and HN (metastatic). Both of the cells expressed several gelatinases. In addition, BHY cells secreted proMMP7 and procathepsin L,while HN cells secreted a large amount of active MMP2. HN cells secreted TIMP1, but only a trace level of TIMP2. The net activity of MMP2 and cathepsin L secreted from cancer cells may contribute respective to lymph node metastasis and the bone invasion of oral cancer cells.We examined the gelatinases in human oral SCC tissues by a microdissection-zymography. The gelatinolytic activities in cancer cell nests were much higher than those of normal gingival epithelium. The activities of active-MMP2 in cancer cell nests of metastatic cancers were significantly higher than those of non-metastatic cancers (p<0.05). We also examined the existence of circulating cancer cells in the peripheral blood of oral SCC patients by RT-PCR for cytokeratin 20 (CK20) mRNA.Eleven of 12 oral SCC patients showed positive results. However, there is no clear relationship of hematogenous CK20 mRNA for metastasis. All of the tumor-free survivors showed negative results. The expression of active-MMP2 in cancer cells can be used as a predictive marker for metastasis, and CK20 mRNA in peripheral blood can be used as a marker for tumor-recurrence in oral SCC patients.We isolated a growth suppressor gene, TSC-22. Then we analyzed the role of the gene on metastatic potentials of oral cancers. However, transfection of either sense or antisense TSC-22 gene did not affect the metastatic potentials of TYS cells. Futhermore, there was no significant difference in the expression of TSC-22 mRNA between metastatic oral cancers and none-metastatic oral cancers.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
Kawamata et al.: "Active MMP2 expression and hematogeneous cytokeratin 20 mRNA as a prodictive marker for metastasis and recurrence inoral cancer patients." British Journal of Cencer. (in press). (1998)
Kawamata 等人:“活性 MMP2 表达和血源性细胞角蛋白 20 mRNA 作为口腔癌患者转移和复发的预测标志物。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kawamata H,Uchida D,Hamano H,Kimura-Yanagawa T,Nakashiro K,Hino S,Omotehara F,Yoshida H and Sato M: "Active MMP2 expression and hematogeneous cytokeratin 20 mRNA as a predictive marker for metastasis and recurrence in oral cancer patients." British J Canc
Kawamata H、Uchida D、Hamano H、Kimura-Yanakawa T、Nakashiro K、Hino S、Omotehara F、Yoshida H 和 Sato M:“活性 MMP2 表达和血源性细胞角蛋白 20 mRNA 作为口腔癌患者转移和复发的预测标志物
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kawamata et al.: "Induction of TSC-22 by treatment with a new anti-cancer drug,vesnarinone,In a human salivary gland cancer" British Journal of Cancer. 77・1. 71-78 (1998)
Kawamata 等人:“用新的抗癌药物维纳里酮治疗人类唾液腺癌诱导 TSC-22”,《英国癌症杂志》77・1(1998 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kawamata et al.: "Active MMP2 expression and homatogeneous Cytokeratin 20 mRNA as a predictive marker for netastasis and recurrence in oral cancer pationt" British Journal of Cancer. (in press). (1998)
Kawamata 等人:“活性 MMP2 表达和同质细胞角蛋白 20 mRNA 作为口腔癌转移和复发的预测标记”《英国癌症杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
16
    Mechanism for acquiring the oncogenic function in mutated p53
    • 批准号:
      17592103
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.37万
    • 财政年份:
      2005
    • 负责人:
      KAWAMATA Hitoshi
    • 依托单位:
    Clinical significance of oncogenic mutations of p53 gene in oral cancen : Relationship of the mutations with radiation- and chemo-sensitivity
    • 批准号:
      15592131
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2003
    • 负责人:
      KAWAMATA Hitoshi
    • 依托单位:
    Molecular diagnosis for occult oral cancer
    • 批准号:
      10671887
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.43万
    • 财政年份:
      1998
    • 负责人:
      KAWAMATA Hitoshi
    • 依托单位:
    国内基金
    海外基金
    泛素连接酶TRIM65通过RhoGAP调控Rho活性促进结直肠癌侵袭转移的分子机制
    • 批准号:
      31970703
    • 项目类别:
      面上项目
    • 资助金额:
      50.0万元
    • 批准年份:
      2019
    • 负责人:
      陈代词
    • 依托单位:
    幽门螺杆菌感染促进肿瘤相关成纤维细胞与胃癌细胞的互作及机制研究
    • 批准号:
      31760328
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      36.0万元
    • 批准年份:
      2017
    • 负责人:
      周建奖
    • 依托单位:
    LncRNA-GMAN调控胃癌细胞侵袭和转移的分子作用机制研究
    • 批准号:
      31771540
    • 项目类别:
      面上项目
    • 资助金额:
      59.0万元
    • 批准年份:
      2017
    • 负责人:
      卓巍
    • 依托单位:
    Hedgehog通路调控长链非编码RNA对胰腺癌增殖侵袭的影响及机制研究
    • 批准号:
      81172184
    • 项目类别:
      面上项目
    • 资助金额:
      65.0万元
    • 批准年份:
      2011
    • 负责人:
      杨尹默
    • 依托单位: